Product Details for ANDA 078109
OLANZAPINE (OLANZAPINE)
5MG
Marketing Status: Prescription
10MG
Marketing Status: Prescription
15MG
Marketing Status: Prescription
20MG
Marketing Status: Prescription
5MG
Marketing Status: Prescription
Active Ingredient: OLANZAPINE
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A078109
Product Number: 001
Approval Date: Oct 24, 2011
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
OLANZAPINE (OLANZAPINE)
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A078109
Product Number: 001
Approval Date: Oct 24, 2011
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
10MG
Marketing Status: Prescription
Active Ingredient: OLANZAPINE
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A078109
Product Number: 002
Approval Date: Oct 24, 2011
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
OLANZAPINE (OLANZAPINE)
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A078109
Product Number: 002
Approval Date: Oct 24, 2011
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
15MG
Marketing Status: Prescription
Active Ingredient: OLANZAPINE
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A078109
Product Number: 003
Approval Date: Oct 24, 2011
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
OLANZAPINE (OLANZAPINE)
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A078109
Product Number: 003
Approval Date: Oct 24, 2011
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
20MG
Marketing Status: Prescription
Active Ingredient: OLANZAPINE
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A078109
Product Number: 004
Approval Date: Oct 24, 2011
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A078109
Product Number: 004
Approval Date: Oct 24, 2011
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status: Prescription
Patent and Exclusivity Information